BioAbsorb

Name: BioAbsorb
SKU: 14258
Availability: InStock

$199.00

Description

BioAbsorb

BioAbsorb is a metabolic research formula marketed by BioLongevity Labs. It combines pharmaceutical and supplement ingredients aimed at supporting glucose disposal, insulin sensitivity, lipid health, mitochondrial function, and methylation. It is sold strictly for investigational/research use only and is not intended for human consumption or medical treatment.

Key Ingredients (Per Capsule)

Metformin — 125 mg (prescription antidiabetic drug)
Dihydroberberine — 125 mg (highly bioavailable form of berberine)
Vitamin B1 (Thiamin) — 12.5 mg
Vitamin B2 (Riboflavin) — 12.5 mg
Vitamin B5 (Pantethine) — 12.5 mg
Vitamin B6 (Pyridoxal-5-Phosphate) — 17.5 mg
Vitamin B9 (Methylfolate) — 200 mcg
Vitamin B12 (Methylcobalamin) — 50 mcg

Pharmacology & Intended Mechanisms

The formula targets dual AMPK activation (via metformin and dihydroberberine) to enhance insulin sensitivity and glucose uptake. Activated B vitamins support mitochondrial energy production, lipid metabolism, homocysteine regulation, and methylation pathways.

Safety Profile

Metformin (125 mg) is a pharmacologically active dose. At this level, common side effects include:

Gastrointestinal issues (nausea, diarrhea, bloating, stomach pain, loss of appetite) — often the most frequent complaint.
Vitamin B12 deficiency with long-term use.
Rare but serious: Lactic acidosis (especially in people with kidney impairment, dehydration, or alcohol use).

Dihydroberberine is generally better tolerated than standard berberine but may still cause digestive upset, constipation, or low blood sugar (hypoglycemia) when combined with metformin.

Activated B Vitamins are typically very safe at these doses, though high B6 can cause nerve issues with prolonged excessive intake (rare at 17.5 mg).

Potential Risks and Adverse Effects

Gastrointestinal Distress — High likelihood due to metformin and berberine derivatives.
Hypoglycemia — Especially when combined with other blood sugar-lowering agents or fasting.
Cardiovascular / Metabolic — Possible blood pressure or heart rate changes; lactic acidosis risk in vulnerable individuals.
Long-term Unknowns — Limited clinical data on this specific combination for healthy adults. Chronic use may affect gut microbiome, nutrient absorption, or kidney function.
Drug Interactions — High risk with other antidiabetics, alcohol, certain blood pressure medications, or drugs cleared by kidneys.

Contraindications

Kidney or liver impairment
History of lactic acidosis
Pregnancy or breastfeeding
Gastrointestinal disorders (e.g., IBS, ulcers)
Concurrent use of other metformin-containing products

Important Note: This is a neutral, educational overview based on known pharmacology of the ingredients and product details. BioAbsorb contains prescription-strength metformin, making it significantly different from standard dietary supplements. There are no specific clinical safety trials on this exact formulation. Significant uncertainties exist regarding long-term safety. This information is not medical advice and does not encourage use. Consult a qualified healthcare professional before considering any research compound, especially those containing pharmaceuticals. Comply with all local laws and regulations.

Delivery Details

2-3 days from the time of purchase to all locations

Order now and enjoy great discounts! We deliver top-quality peptide products straight to you. Fast, reliable, and discreet service. Delivery hours: 10 AM–8 PM daily. Don’t miss out

Research

Glucose Disposal & Insulin Sensitivity

Metformin activates hepatic and skeletal-muscle AMPK, suppressing gluconeogenesis and potentiating insulin-stimulated glucose uptake [1] . Dihydroberberine, a reduced berberine metabolite with far superior intestinal absorption, demonstrated greater area-under-the-curve exposure and produced acute reductions in post-prandial glucose in a randomized crossover pilot trial [2] .

Lipid & Endothelial Support

Pantethine (vitamin B₅ derivative) lowered total and LDL cholesterol by 11 % over 16 weeks in a triple-blinded, diet-controlled trial [5] . Low-dose thiamine reversed hyperglycemia-induced endothelial cell dysfunction in vitro, restoring migration capacity and reducing von Willebrand factor secretion [3] . Riboflavin supplementation (1.6 mg day⁻¹) produced clinically meaningful blood-pressure reductions in treated hypertensives carrying the MTHFR 677TT polymorphism [4] .

Methylation & Homocysteine Management

In a randomized controlled trial, combined methyl-folate (5-MTHF), PLP and methyl-cobalamin lowered plasma homocysteine by 30 % and LDL-C by 7.5 % after six months in adults with MTHFR/MTR/MTRR polymorphisms [7] . Independent PLP supplementation has likewise been shown to cut homocysteine while enhancing antioxidant capacity in postsurgical patients [6] .

Neuroprotection & Nerve Health

A 2020 systematic review and meta-analysis of randomized trials found that mecobalamin (methyl-B₁₂) significantly improved nerve-conduction velocity and overall clinical response in peripheral neuropathy, with a favorable safety profile [8] .

References

Zhou G et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108:1167-1174. https://pubmed.ncbi.nlm.nih.gov/11602624/
Moon JM et al. Absorption kinetics of berberine and dihydroberberine and their impact on glycemia. Nutrients. 2022;14(1):124. https://pubmed.ncbi.nlm.nih.gov/35010998/
Ascher E et al. Thiamine reverses hyperglycemia-induced dysfunction in cultured endothelial cells. Surgery. 2001;130:851-858. https://pubmed.ncbi.nlm.nih.gov/11685195/
Wilson CP et al. Blood pressure in hypertensive individuals with the MTHFR 677TT genotype is responsive to riboflavin: targeted randomized trial. Hypertension. 2013;61:1302-1308. https://pubmed.ncbi.nlm.nih.gov/23608654/
Evans M et al. Pantethine favorably alters LDL and non-HDL cholesterol in low-to-moderate risk subjects. Vasc Health Risk Manag. 2014;10:89-100. https://pubmed.ncbi.nlm.nih.gov/24600231/
Cheng SB et al. Vitamin B-6 supplementation reduces plasma homocysteine in hepatocellular-carcinoma patients after resection. Biomed Res Int. 2016;2016:7658981. https://pubmed.ncbi.nlm.nih.gov/27051670/
Pokushalov E et al. Methylfolate, PLP and methylcobalamin supplementation lowers homocysteine and LDL-C: randomized controlled trial. Nutrients. 2024;16:1550. https://pubmed.ncbi.nlm.nih.gov/38892484/
Sawangjit R et al. Efficacy and safety of mecobalamin on peripheral neuropathy: systematic review and meta-analysis. J Altern Complement Med. 2020;26:1117-1129. https://pubmed.ncbi.nlm.nih.gov/32716261/

Note: BioAbsorb is supplied strictly for investigational research use only. It is not approved or intended for diagnostic or therapeutic applications in humans or animals.

COAs